Explore more publications!

Healthcare Today Bahrain: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Today Bahrain.

Press releases published on April 22, 2026

Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100)
Press Release: Sanofi and Regeneron’s Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria
Communiqué de presse :  Dupixent, développé par Sanofi et Regeneron, a été approuvé aux États-Unis comme étant le premier médicament biologique pour les jeunes enfants atteints d’urticaire chronique spontanée non contrôlée
Dupixent® (dupilumab) Approved in the U.S. as the First Biologic Medicine for Young Children with Uncontrolled Chronic Spontaneous Urticaria (CSU)
George Medicines: New England Journal of Medicine publishes global stroke outcomes trial that demonstrated reduction of risk for recurrent stroke by almost 40% with GMRx2 in patients with previous intracerebral hemorrhage
Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
Sight Sciences Announces the Release of its Sustainability Report
Plus Therapeutics Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Altimmune Announces Proposed Underwritten Public Offering of Securities
Dentsply Sirona to Host First Quarter 2026 Conference Call on May 5
Silo Pharma Announces Strategic Business Expansion into Multi-Billion Dollar AI Agent Market with Acquisition of Managed AI Agent Platform, Qwikagents
Supernus Pharmaceuticals to Announce First Quarter 2026 Financial Results and Host Conference Call on May 5, 2026
RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6
OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th
Abivax to Present Data on Obefazimod at Digestive Disease Week®
SkinHealth Systems Inc. Appoints Three New Independent Directors to Board
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels
BBOT Presents Preclinical Data Demonstrating pan-KRAS Inhibitor BBO-11818 Has Robust Anti-Tumor Activity in KRAS-Mutant Preclinical Models at the AACR Annual Meeting 2026
LB Pharmaceuticals Announces Publication in JAMA Psychiatry of Results from Phase 2 NOVA-1 Trial of LB-102 in Schizophrenia

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions